Cargando…
Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit
SIMPLE SUMMARY: Cancer patients are vulnerable to the SARS-CoV-2 infection. Their treatment has also been negatively affected by the COVID-19 pandemic. No solid data exist regarding the appropriate management of cancer patients during the pandemic. Our center, a referral oncology/hematology unit, ha...
Autores principales: | Liontos, Michalis, Kastritis, Efstathios, Markellos, Christos, Migkou, Magdalini, Eleftherakis-Papaiakovou, Evangelos, Koutsoukos, Konstantinos, Gavriatopoulou, Maria, Zagouri, Flora, Psaltopoulou, Theodora, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918613/ https://www.ncbi.nlm.nih.gov/pubmed/33673120 http://dx.doi.org/10.3390/cancers13040763 |
Ejemplares similares
-
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
por: Paschou, Stavroula A., et al.
Publicado: (2022) -
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
por: Zagouri, Flora, et al.
Publicado: (2021) -
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
por: Liontos, Michalis, et al.
Publicado: (2021) -
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
por: Liontos, Michalis, et al.
Publicado: (2021) -
Emerging treatment strategies for COVID-19 infection
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)